04.06.2018
Steffen Saltofte appointed CEO Acino Group
Acino is pleased to announce that Steffen Saltofte has joined the company as CEO Acino Group. Steffen is a highly...
News
24.04.2018
Acino relaunches Contract Manufacturing
We are excited to share that we have re-launched our Contract Manufacturing offer under our new brand “Acino Contract Manufacturing”....
29.09.2017
Acino acquires products from Tabuk
Acino announces the accomplishment of another important partnership, which is further developing its business in the Middle East and Africa.Acino...
31.07.2017
Merck and Acino signed a distribution agreement
Acino will commercialize present 9 Merck products for the treatment of cardiovascular and endocrine diseases in Ukraine, Armenia, Azerbaijan, Kazakhstan,...
03.07.2017
Acino acquires Litha Healthcare
Acino has acquired South Africa’s Litha Healthcare. Litha, headquartered in Johannesburg, provides services and products to public and private hospitals,...
28.02.2017
Acino to acquire Litha Healthcare in South Africa
Acino signed a deal with certain subsidiaries of Endo International plc to acquire Litha Healthcare in South Africa. Litha Healthcare,...
15.02.2017
Appointment of Mario Ricard as COO and member of the Executive Committee
Acino announces the appointment of Mario Ricard as Chief Operations Officer and member of the Executive Committee effective February 15,...
23.01.2017
Resignation of Barthold Piening, Chief Operations Officer
Barthold Piening, Chief Operations Officer and Member of the Executive Committee, has decided to leave Acino by mid of this...
30.11.2016
Acino closes the deal to divest its patch business to Luye Pharma Group Ltd.
On November 30, 2016, Acino International AG and Acino Pharma AG (together “Acino”) closed the deal with Luye Pharma Group...